Cure My Disease

Don't miss your cure!

 Log in / Sign up

Shoulder surgery breakthrough? bone injection may give surgeons a clearer view

NCT ID NCT07714473

Disease control Sponsor: Hua Luo Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time

Summary

This trial tests whether injecting tranexamic acid into the shoulder bone before rotator cuff repair improves the surgeon's view during the procedure. Sixty adults scheduled for arthroscopic rotator cuff repair will receive either the drug or a placebo. The goal is to see if this technique reduces bleeding and makes surgery smoother.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
tranexamic acid injected into the shoulder bone
What this could lead to
If it works, this approach could make rotator cuff surgery clearer and more efficient, possibly reducing complications and improving recovery.
What could go wrong
This is a small early-stage trial, so results may not apply to all patients. The injection itself carries risks like allergic reaction or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age between 18 and 80 years; * Patients diagnosed with rotator cuff tear by shoulder MRI; * Patients scheduled for arthroscopic rotator cuff repair; * Ability to understand the study and provide written informed consent. Exclusion Criteria: * Severe open injury or infection around the surgical area; * Allergy to tranexamic acid; * Previous shoulder surgery; * Coagulation disorders; * Current anticoagulant therapy that cannot be discontinued; * Pregnancy.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Rotator cuff tear are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

rotator cuff syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Rotator cuff tear repair

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • No. 150 Ximen Road

    Linhai, Zhejiang, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.